Company intelligence / Profile preview

HumanN

Austin, Texas, United Stateshumann.com ↗
Ownership
Private
Employees
~75
Development stage
Commercial
01

Overview

HumanN develops science-backed functional foods and nutritional supplements focused on supporting cardiovascular health through nitric oxide production. Their portfolio includes SuperBeets, Neo40, BeetElite, and other nutrition-based products. The company has completed ten clinical trials on their products in collaboration with academic institutions but does not develop prescription drugs or biologics. Products are widely used by consumers as well as professional athletes and medical professionals. Clinical results focus on efficacy for supporting healthy blood pressure and circulation rather than treating specific diseases. The company has received several awards for growth and scientific innovation in the nutrition sector. No traditional pharmaceutical pipeline exists.

Therapeutic areas
OtherCardiovascular
Modalities
Functional foodNutritional supplement
Industry
Food & Nutrition
02

Drug pipeline

3 assets

SuperBeets Heart Chews

Commercial
Indications
Heart health, Blood pressure, Energy

2 more assets in the full pipeline.

Request access →
03

Partnerships

University of Texas Health Science CenterCedars-Sinai Medical CenterUniversity of Iowa

Beyond the preview

Go deeper on HumanN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HumanN.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call